483 related articles for article (PubMed ID: 14999699)
21. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
Martin RC; Loehle J; Scoggins CR; McMasters KM
Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
[TBL] [Abstract][Full Text] [Related]
22. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.
El-Serag HB; Mason AC; Key C
Hepatology; 2001 Jan; 33(1):62-5. PubMed ID: 11124821
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis.
Shibuya A; Tanaka K; Miyakawa H; Shibata M; Takatori M; Sekiyama K; Hashimoto N; Amaki S; Komatsu T; Morizane T
Hepatology; 2002 May; 35(5):1172-8. PubMed ID: 11981767
[TBL] [Abstract][Full Text] [Related]
24. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
[TBL] [Abstract][Full Text] [Related]
25. Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan.
Arii S; Okamoto E; Imamura M
Semin Surg Oncol; 1996; 12(3):204-11. PubMed ID: 8727612
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns.
Verhoef C; Visser O; de Man RA; de Wilt JH; IJzermans JN; Janssen-Heijnen ML
Eur J Cancer; 2004 Jul; 40(10):1530-8. PubMed ID: 15196537
[TBL] [Abstract][Full Text] [Related]
27. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
[TBL] [Abstract][Full Text] [Related]
28. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
29. Results of hepatic resection and transplantation for fibrolamellar carcinoma.
Ringe B; Wittekind C; Weimann A; Tusch G; Pichlmayr R
Surg Gynecol Obstet; 1992 Oct; 175(4):299-305. PubMed ID: 1329242
[TBL] [Abstract][Full Text] [Related]
30. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
Cho SJ; Yoon JH; Hwang SS; Lee HS
J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220
[TBL] [Abstract][Full Text] [Related]
31. Utilization of screening for hepatocellular carcinoma in the United States.
Davila JA; Weston A; Smalley W; El-Serag HB
J Clin Gastroenterol; 2007 Sep; 41(8):777-82. PubMed ID: 17700427
[TBL] [Abstract][Full Text] [Related]
32. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
[TBL] [Abstract][Full Text] [Related]
33. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
[TBL] [Abstract][Full Text] [Related]
35. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.
Leykum LK; El-Serag HB; Cornell J; Papadopoulos KP
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):508-12. PubMed ID: 17382601
[TBL] [Abstract][Full Text] [Related]
36. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
37. Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience.
Jan CF; Chen CJ; Chen HH
J Gastroenterol Hepatol; 2005 Apr; 20(4):521-6. PubMed ID: 15836699
[TBL] [Abstract][Full Text] [Related]
38. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
39. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences.
Evans AA; Chen G; Ross EA; Shen FM; Lin WY; London WT
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):369-76. PubMed ID: 11927497
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma in the youth. A comparative analysis with hepatocellular carcinoma in adulthood.
Hernández-Castillo E; Mondragón-Sánchez R; Garduno-Lopez AL; Gómez-Gómez E; Ruiz-Molina JM; Oñate-Ocaña LF; Bernal-Maldonado R
Hepatogastroenterology; 2005; 52(63):903-7. PubMed ID: 15966229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
